Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
A multicenter study to define sarcopenia in patients with end-stage liver disease.
Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.
Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Decision support for organ offers in liver transplantation.
Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
